GGrantIndex
← Leaderboards

Jodi B Segal

Johns Hopkins University

$8,730,401
Attributed
$10,170,801
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,233,877 · 6
FDA$3,528,431 · 2
AHRQ$3,408,492 · 4

By mechanism

U01$3,528,431 · 2
P30$3,375,492 · 3
T32$2,128,600 · 1
K24$1,583,637 · 1
R33$429,915 · 1
K23$400,539 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Indexing

Research focus

IndexingFrailtyResourcesFamilyServicesPreferenceElderlyHeterogeneityCostAgingPatient OrientedMedicareMethodologyMid-Career Clinical Scientist Award (K24)MentorsCaringHealthcareHealthcare SystemsMedicare ClaimCare DeliveryCareerDesignMedicineOlder Patient

Grant awards (35)

Promoting Embedded Research in a Learning Health System$999,999
P30 · FY2025 · HS · contact PI
Research Education Core$528,522
P30 · FY2025 · HS · contact PI
Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance an efficient and fair use of novel treatments for Alzheimer’s Disease and Related Dementias$429,915
R33 · FY2025 · AG · contact PI
NHLBI Training Program in Pharmacoepidemiology$339,844
T32 · FY2025 · HL
Admin$160,017
P30 · FY2025 · HS · contact PI
Promoting Embedded Research in a Learning Health System$1,000,000
P30 · FY2024 · HS · contact PI
Research Education Core$507,203
P30 · FY2024 · HS · contact PI
Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance health equity in use of novel treatments for Alzheimer's Disease and Related Dementias$322,286
R61 · FY2024 · AG · contact PI
NHLBI Training Program in Pharmacoepidemiology$317,361
T32 · FY2024 · HL
Admin$179,751
P30 · FY2024 · HS · contact PI
Towards Reduction of Harmful Overuse of Healthcare in Older Adults$157,358
K24 · FY2024 · AG · contact PI
Towards Reduction of Harmful Overuse of Healthcare in Older Adults$157,358
K24 · FY2023 · AG · contact PI
Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI)$1,357,484
U01 · FY2022 · FD · contact PI
NHLBI Training Program in Pharmacoepidemiology$212,451
T32 · FY2022 · HL
Towards Reduction of Harmful Overuse of Healthcare in Older Adults$152,822
K24 · FY2022 · AG · contact PI
Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI)$1,730,521
U01 · FY2021 · FD · contact PI
NHLBI Training Program in Pharmacoepidemiology$354,642
T32 · FY2021 · HL
Towards Reduction of Harmful Overuse of Healthcare in Older Adults$153,902
K24 · FY2021 · AG · contact PI
NHLBI Training Program in Pharmacoepidemiology$347,125
T32 · FY2020 · HL
Towards Reduction of Harmful Overuse of Healthcare in Older Adults$164,902
K24 · FY2020 · AG · contact PI
NHLBI Training Program in Pharmacoepidemiology$307,722
T32 · FY2019 · HL
Towards Understanding the Patient Experience of Overuse of Medical Resources$159,459
K24 · FY2019 · AG · contact PI
NHLBI Training Program in Pharmacoepidemiology$249,455
T32 · FY2018 · HL
Towards Understanding the Patient Experience of Overuse of Medical Resources$159,459
K24 · FY2018 · AG · contact PI
Towards Understanding the Patient Experience of Overuse of Medical Resources$159,459
K24 · FY2017 · AG · contact PI
Towards Understanding the Patient Experience of Overuse of Medical Resources$159,459
K24 · FY2016 · AG · contact PI
Effect of Therapeutic Class on Generic Drug Substitutions$220,213
U01 · FY2015 · FD · contact PI
Creating and Validating a Claim-based Indicator of Frailty$164,900
R21 · FY2015 · AG · contact PI
Towards Understanding the Patient Experience of Overuse of Medical Resources$159,459
K24 · FY2015 · AG · contact PI
Effect of Therapeutic Class on Generic Drug Substitutions$220,213
U01 · FY2014 · FD · contact PI
Creating and Validating a Claim-based Indicator of Frailty$204,000
R21 · FY2014 · AG · contact PI
Curricular standards for comparative effectiveness research$33,000
R13 · FY2013 · HS · contact PI
Immune Thrombocytopenia and Low-Level Mercury Exposure$131,565
K23 · FY2006 · ES · contact PI
Immune Thrombocytopenia and Low-Level Mercury Exposure$134,730
K23 · FY2005 · ES
Immune Thrombocytopenia and Low-Level Mercury Exposure$134,244
K23 · FY2004 · ES